A Phase I, Open-lable, Randomized, Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Different Antihyperglycemic Drugs in the Treatment of Pasireotide-associated Hyperglycemia.
Phase of Trial: Phase I
Latest Information Update: 01 Dec 2015
At a glance
- Drugs Liraglutide (Primary) ; Metformin (Primary) ; Nateglinide (Primary) ; Pasireotide (Primary) ; Vildagliptin (Primary)
- Indications Acromegaly; Gastrointestinal cancer; Gastrointestinal disorders; Gigantism; Liver cancer; Malignant melanoma; Meningioma; Merkel cell carcinoma; Neuroendocrine tumours; Obesity; Pancreatic cancer; Pancreatic disorders; Pituitary cancer; Prostate cancer; Type 1 diabetes mellitus; Type 2 diabetes mellitus; Uveal melanoma
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 01 Dec 2015 New trial record